Operating Expenses Summary of Pfizer Inc.

Pfizer Inc.'s latest annual operating expenses in 2023 was 25.45 Billion USD , down -12.77% from previous year.
Pfizer Inc.'s latest quarterly operating expenses in 2024 Q3 was 7.15 Billion USD , down -8.2% from previous quarter.
Pfizer Inc. reported a annual operating expenses of 28.71 Billion USD in annual operating expenses 2022, down -5.02% from previous year.
Pfizer Inc. reported a annual operating expenses of 30.23 Billion USD in annual operating expenses 2021, up 23.62% from previous year.
Pfizer Inc. reported a quarterly operating expenses of 6.36 Billion USD for 2024 Q2, up 7.16% from previous quarter.
Pfizer Inc. reported a quarterly operating expenses of 7.15 Billion USD for 2024 Q3, down -8.2% from previous quarter.

Annual Operating Expenses Chart of Pfizer Inc. (2023 - 1989)

Historical Annual Operating Expenses of Pfizer Inc. (2023 - 1989)

Year	Operating Expenses	Operating Expenses Growth
2023	25.45 Billion USD	-12.77%
2022	28.71 Billion USD	-5.02%
2021	30.23 Billion USD	23.62%
2020	24.45 Billion USD	-11.42%
2019	27.61 Billion USD	0.94%
2018	27.35 Billion USD	0.57%
2017	27.19 Billion USD	1.62%
2016	26.76 Billion USD	2.05%
2015	26.22 Billion USD	-1.14%
2014	26.52 Billion USD	3.5%
2013	25.63 Billion USD	-13.58%
2012	29.66 Billion USD	-13.18%
2011	34.16 Billion USD	-8.58%
2010	37.37 Billion USD	44.35%
2009	25.88 Billion USD	2.94%
2008	25.15 Billion USD	-6.31%
2007	26.84 Billion USD	1.49%
2006	26.44 Billion USD	-5.02%
2005	27.84 Billion USD	-0.37%
2004	27.95 Billion USD	13.83%
2003	24.55 Billion USD	53.0%
2002	16.05 Billion USD	-1.22%
2001	16.24 Billion USD	-3.54%
2000	16.84 Billion USD	74.22%
1999	9.66 Billion USD	15.99%
1998	8.33 Billion USD	12.86%
1997	7.38 Billion USD	13.98%
1996	6.48 Billion USD	14.26%
1995	5.67 Billion USD	21.12%
1994	4.68 Billion USD	-7.29%
1993	5.05 Billion USD	25.44%
1992	4.02 Billion USD	7.66%
1991	3.74 Billion USD	12.73%
1990	3.31 Billion USD	16.48%
1989	2.84 Billion USD	11.78%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	5.93 Billion USD	-18.08%
2024 Q2	6.36 Billion USD	7.16%
2024 Q3	7.15 Billion USD	-8.2%
2023 FY	25.04 Billion USD	-12.77%
2023 Q1	5.85 Billion USD	-37.66%
2023 Q2	6.06 Billion USD	3.55%
2023 Q3	5.89 Billion USD	-2.76%
2023 Q4	7.25 Billion USD	23.01%
2022 Q3	6.9 Billion USD	20.6%
2022 Q1	5.72 Billion USD	-47.8%
2022 Q2	5.72 Billion USD	0.0%
2022 FY	28.71 Billion USD	-5.02%
2022 Q4	9.38 Billion USD	35.9%
2021 Q1	5.66 Billion USD	-28.84%
2021 Q2	6.31 Billion USD	11.45%
2021 Q4	10.97 Billion USD	49.68%
2021 Q3	7.33 Billion USD	16.07%
2021 FY	30.23 Billion USD	23.62%
2020 Q1	5.48 Billion USD	-32.27%
2020 Q4	7.96 Billion USD	26.98%
2020 Q3	6.27 Billion USD	3.41%
2020 Q2	6.06 Billion USD	10.67%
2020 FY	24.45 Billion USD	-11.42%
2019 Q1	6.22 Billion USD	-19.33%
2019 FY	27.61 Billion USD	0.94%
2019 Q4	8.09 Billion USD	19.82%
2019 Q3	6.75 Billion USD	3.33%
2019 Q2	6.53 Billion USD	5.01%
2018 Q2	6.53 Billion USD	2.82%
2018 Q1	6.35 Billion USD	-21.1%
2018 FY	27.35 Billion USD	0.57%
2018 Q4	7.71 Billion USD	14.24%
2018 Q3	6.75 Billion USD	3.45%
2017 Q1	6.2 Billion USD	-23.01%
2017 Q4	8.04 Billion USD	23.15%
2017 Q3	6.53 Billion USD	1.92%
2017 Q2	6.41 Billion USD	3.4%
2017 FY	27.19 Billion USD	1.62%
2016 FY	26.76 Billion USD	2.05%
2016 Q4	8.05 Billion USD	25.72%
2016 Q2	6.18 Billion USD	0.95%
2016 Q3	6.4 Billion USD	3.69%
2016 Q1	6.12 Billion USD	-26.91%
2015 Q1	5.92 Billion USD	-27.15%
2015 Q2	5.99 Billion USD	1.06%
2015 Q3	5.92 Billion USD	-1.05%
2015 FY	26.22 Billion USD	-1.14%
2015 Q4	8.37 Billion USD	41.27%
2014 Q3	6.33 Billion USD	0.8%
2014 Q2	6.28 Billion USD	8.65%
2014 Q1	5.78 Billion USD	-18.43%
2014 FY	26.52 Billion USD	3.5%
2014 Q4	8.13 Billion USD	28.58%
2013 Q4	7.08 Billion USD	15.43%
2013 Q3	6.13 Billion USD	-1.95%
2013 Q2	6.26 Billion USD	-5.41%
2013 FY	25.63 Billion USD	-13.58%
2013 Q1	6.61 Billion USD	-19.15%
2012 Q1	7.62 Billion USD	-18.74%
2012 Q2	6.96 Billion USD	-8.63%
2012 Q3	7.05 Billion USD	1.28%
2012 Q4	8.18 Billion USD	16.03%
2012 FY	29.66 Billion USD	-13.18%
2011 Q2	8.6 Billion USD	-2.18%
2011 FY	34.16 Billion USD	-8.58%
2011 Q4	9.38 Billion USD	14.36%
2011 Q3	8.2 Billion USD	-4.64%
2011 Q1	8.79 Billion USD	-19.45%
2010 Q1	8.48 Billion USD	-7.52%
2010 FY	37.37 Billion USD	44.35%
2010 Q4	10.92 Billion USD	5.66%
2010 Q3	10.33 Billion USD	19.19%
2010 Q2	8.67 Billion USD	2.2%
2009 Q4	9.17 Billion USD	61.87%
2009 Q2	5.72 Billion USD	12.11%
2009 Q1	5.1 Billion USD	-22.31%
2009 Q3	5.66 Billion USD	-0.91%
2009 FY	25.88 Billion USD	2.94%
2008 Q4	6.56 Billion USD	8.92%
2008 Q2	6.49 Billion USD	7.09%
2008 FY	25.15 Billion USD	-6.31%
2008 Q3	6.02 Billion USD	-7.13%
2008 Q1	6.06 Billion USD	-20.95%
2007 Q1	5.84 Billion USD	-25.01%
2007 Q3	6.54 Billion USD	-3.7%
2007 FY	26.84 Billion USD	1.49%
2007 Q2	6.79 Billion USD	16.28%
2007 Q4	7.66 Billion USD	17.25%
2006 Q4	7.78 Billion USD	20.74%
2006 Q2	6.44 Billion USD	3.53%
2006 Q1	6.22 Billion USD	-18.18%
2006 FY	26.44 Billion USD	-5.02%
2006 Q3	6.45 Billion USD	0.08%
2005 Q3	6.55 Billion USD	-5.89%
2005 Q2	6.96 Billion USD	3.4%
2005 Q1	6.73 Billion USD	-14.49%
2005 FY	27.84 Billion USD	-0.37%
2005 Q4	7.6 Billion USD	16.17%
2004 FY	27.95 Billion USD	13.83%
2004 Q4	7.87 Billion USD	16.33%
2004 Q3	6.76 Billion USD	-2.03%
2004 Q2	6.9 Billion USD	23.74%
2004 Q1	5.58 Billion USD	-30.23%
2003 Q2	6.07 Billion USD	53.18%
2003 Q4	8 Billion USD	22.47%
2003 Q3	6.53 Billion USD	7.52%
2003 FY	24.55 Billion USD	53.0%
2003 Q1	3.96 Billion USD	11.84%
2002 FY	16.05 Billion USD	-1.22%
2002 Q3	4.21 Billion USD	-1.03%
2002 Q1	4.03 Billion USD	-15.66%
2002 Q4	3.54 Billion USD	-15.83%
2002 Q2	4.25 Billion USD	5.5%
2001 Q1	3.63 Billion USD	-21.0%
2001 Q2	3.95 Billion USD	8.73%
2001 Q4	4.78 Billion USD	23.24%
2001 FY	16.24 Billion USD	-3.54%
2001 Q3	3.88 Billion USD	-1.72%
2000 Q2	4.28 Billion USD	69.98%
2000 FY	16.84 Billion USD	74.22%
2000 Q4	4.59 Billion USD	23.53%
2000 Q3	3.72 Billion USD	-13.16%
2000 Q1	2.52 Billion USD	-5.4%
1999 Q1	2.35 Billion USD	-2.85%
1999 Q3	2.3 Billion USD	-1.92%
1999 FY	9.66 Billion USD	15.99%
1999 Q2	2.34 Billion USD	-0.21%
1999 Q4	2.66 Billion USD	15.76%
1998 Q1	1.97 Billion USD	-6.94%
1998 FY	8.33 Billion USD	12.86%
1998 Q2	2.2 Billion USD	12.02%
1998 Q3	2.04 Billion USD	-7.2%
1998 Q4	2.42 Billion USD	18.2%
1997 FY	7.38 Billion USD	13.98%
1997 Q2	1.83 Billion USD	11.88%
1997 Q3	1.79 Billion USD	-2.45%
1997 Q4	2.11 Billion USD	18.26%
1997 Q1	1.64 Billion USD	-11.77%
1996 Q1	1.46 Billion USD	-9.31%
1996 Q3	1.54 Billion USD	-7.42%
1996 Q4	1.86 Billion USD	20.16%
1996 FY	6.48 Billion USD	14.26%
1996 Q2	1.67 Billion USD	14.44%
1995 Q3	1.37 Billion USD	-4.28%
1995 Q1	1.33 Billion USD	0.5%
1995 FY	5.67 Billion USD	21.12%
1995 Q4	1.61 Billion USD	17.46%
1995 Q2	1.43 Billion USD	7.24%
1994 Q4	1.32 Billion USD	14.29%
1994 FY	4.68 Billion USD	-7.29%
1994 Q3	1.16 Billion USD	2.78%
1994 Q2	1.13 Billion USD	7.14%
1994 Q1	1.05 Billion USD	-45.18%
1993 Q3	1.05 Billion USD	28.09%
1993 Q2	821 Million USD	-19.37%
1993 Q4	1.92 Billion USD	83.22%
1993 FY	5.05 Billion USD	25.44%
1993 Q1	1.01 Billion USD	-10.08%
1992 FY	4.02 Billion USD	7.66%
1992 Q3	969.5 Million USD	-2.06%
1992 Q2	989.9 Million USD	6.19%
1992 Q1	932.2 Million USD	-10.02%
1992 Q4	1.13 Billion USD	16.79%
1991 Q1	859.1 Million USD	-12.05%
1991 Q2	928 Million USD	8.02%
1991 Q3	916.9 Million USD	-1.2%
1991 Q4	1.03 Billion USD	12.99%
1991 FY	3.74 Billion USD	12.73%
1990 FY	3.31 Billion USD	16.48%
1990 Q4	976.8 Million USD	22.31%
1990 Q3	798.6 Million USD	-1.43%
1990 Q2	810.2 Million USD	10.59%
1990 Q1	732.6 Million USD	115.58%
1989 Q1	- USD	100.0%
1989 Q2	- USD	0.0%
1989 FY	2.84 Billion USD	11.78%
1989 Q4	-4.7 Billion USD	0.0%
1989 Q3	- USD	0.0%

Peer Operating Expenses Comparison of Pfizer Inc.

Name	Operating Expenses	Operating Expenses Difference
AbbVie Inc.	24.83 Billion USD	-2.476%
Bristol-Myers Squibb Company	34.31 Billion USD	25.83%
Bristol-Myers Squibb Company Ce	34.31 Billion USD	25.83%
Johnson & Johnson	58.6 Billion USD	56.574%
Eli Lilly and Company	16.71 Billion USD	-52.245%
Merck & Co., Inc.	43.98 Billion USD	42.145%
Novartis AG	24.87 Billion USD	-2.328%
Organon & Co.	2.41 Billion USD	-952.088%

Global Stocks Search

Pfizer Inc. (PFE)

Operating Expenses Summary of Pfizer Inc.

Annual Operating Expenses Chart of Pfizer Inc. (2023 - 1989)

Historical Annual Operating Expenses of Pfizer Inc. (2023 - 1989)

Peer Operating Expenses Comparison of Pfizer Inc.